Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Loncar Cancer Immunotherapy ETF, ETF

CNCR

NMQ

$12.205

-$0.09

(-0.73%)

Provider: Range Cancer Category: Health

Overview Returns Holdings Sector Breakdown FAQs

Price Chart

Key Metrics

Expense Ratio info-icon

The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.

0.79%

Volume

This is the total number of shares traded during the most recent trading day.

1.94K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.00

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$11.38 L

$17.96 H

$12.205

About Loncar Cancer Immunotherapy ETF, ETF

The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index. more

Provider: Range CancerCategory: Health

Returns

Time Frame	CNCR	S&P500
1-Week Return	-0.2%	-0.32%
1-Month Return	0.29%	2.75%
3-Month Return	-18.8%	3.94%
6-Month Return	-21.21%	11.01%
1-Year Return	-15.83%	23.11%
3-Year Return	-37.04%	34.36%
5-Year Return	-44.13%	85.19%
10-Year Return	-51.35%	200.02%

Time Frame	CNCR	S&P500
1-Week Return	-9.91%	-15.39%
1-Month Return	3.59%	39.11%
3-Month Return	-57.03%	16.97%
6-Month Return	-38.33%	23.59%
1-Year Return	-15.83%	23.11%
3-Year Return	-14.29%	10.35%
5-Year Return	-10.99%	13.12%
10-Year Return	-6.95%	11.61%

Largest Holdings

Stock name	Ticker	Weight
Recursion Pharmaceuticals Inc	RXRX	3.68%
Compass Therapeutics Inc.	CMPX.old	3.08%
Genelux Corporation Common Stock	GNLX	2.52%
Vor Biopharma Inc	VOR	2.22%
Replimune Group Inc	REPL	2.19%
Blueprint Medicines Corp	BPMC	2.17%
Schrodinger Inc	SDGR	2.1%
Precigen Inc	PGEN	2.08%
Exelixis Inc	EXEL	1.94%
Bristol-Myers Squibb Company	BMY	1.92%